questionsmedicales.fr
États, signes et symptômes pathologiques
Signes et symptômes
Manifestations neurologiques
Manifestations neuromusculaires
Manifestations neuromusculaires : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Myopathies
Biopsie musculaire
Neuropathies
Électromyographie
Tests génétiques
Maladies héréditaires
Force musculaire
Évaluation clinique
Imagerie par résonance magnétique
Anomalies musculaires
Symptômes
5
Dystrophies musculaires
Faiblesse musculaire
Neuropathies périphériques
Douleur neuropathique
Myasthénie
Fatigue musculaire
Sclérose latérale amyotrophique
Difficultés de déglutition
Syndrome de Guillain-Barré
Faiblesse musculaire
Prévention
5
Neuropathies
Prévention des maladies
Crampes musculaires
Hydratation
Myopathies
Diagnostic précoce
Blessures musculaires
Échauffement
Sclérose latérale amyotrophique
Prévention
Traitements
5
Myopathies
Corticostéroïdes
Neuropathies diabétiques
Contrôle glycémique
Myasthénie
Inhibiteurs de l'acétylcholinestérase
Sclérose latérale amyotrophique
Soins palliatifs
Syndrome de Guillain-Barré
Immunoglobulines
Complications
5
Myopathies
Complications respiratoires
Neuropathies
Infections cutanées
Myasthénie
Crises myasthéniques
Sclérose latérale amyotrophique
Paralysie
Syndrome de Guillain-Barré
Complications neurologiques
Facteurs de risque
5
Myopathies
Antécédents familiaux
Neuropathies diabétiques
Diabète
Myasthénie
Maladies auto-immunes
Sclérose latérale amyotrophique
Âge avancé
Syndrome de Guillain-Barré
Infections virales
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Manifestations neuromusculaires : Questions médicales les plus fréquentes",
"headline": "Manifestations neuromusculaires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Manifestations neuromusculaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-13",
"dateModified": "2025-04-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Manifestations neuromusculaires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Manifestations neurologiques",
"url": "https://questionsmedicales.fr/mesh/D009461",
"about": {
"@type": "MedicalCondition",
"name": "Manifestations neurologiques",
"code": {
"@type": "MedicalCode",
"code": "D009461",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Fasciculation",
"alternateName": "Fasciculation",
"url": "https://questionsmedicales.fr/mesh/D005207",
"about": {
"@type": "MedicalCondition",
"name": "Fasciculation",
"code": {
"@type": "MedicalCode",
"code": "D005207",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Crampe musculaire",
"alternateName": "Muscle Cramp",
"url": "https://questionsmedicales.fr/mesh/D009120",
"about": {
"@type": "MedicalCondition",
"name": "Crampe musculaire",
"code": {
"@type": "MedicalCode",
"code": "D009120",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hypertonie musculaire",
"alternateName": "Muscle Hypertonia",
"url": "https://questionsmedicales.fr/mesh/D009122",
"about": {
"@type": "MedicalCondition",
"name": "Hypertonie musculaire",
"code": {
"@type": "MedicalCode",
"code": "D009122",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.550"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Raideur musculaire",
"alternateName": "Muscle Rigidity",
"url": "https://questionsmedicales.fr/mesh/D009127",
"about": {
"@type": "MedicalCondition",
"name": "Raideur musculaire",
"code": {
"@type": "MedicalCode",
"code": "D009127",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.550.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Spasticité musculaire",
"alternateName": "Muscle Spasticity",
"url": "https://questionsmedicales.fr/mesh/D009128",
"about": {
"@type": "MedicalCondition",
"name": "Spasticité musculaire",
"code": {
"@type": "MedicalCode",
"code": "D009128",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.550.550"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Hypotonie musculaire",
"alternateName": "Muscle Hypotonia",
"url": "https://questionsmedicales.fr/mesh/D009123",
"about": {
"@type": "MedicalCondition",
"name": "Hypotonie musculaire",
"code": {
"@type": "MedicalCode",
"code": "D009123",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.575"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Faiblesse musculaire",
"alternateName": "Muscle Weakness",
"url": "https://questionsmedicales.fr/mesh/D018908",
"about": {
"@type": "MedicalCondition",
"name": "Faiblesse musculaire",
"code": {
"@type": "MedicalCode",
"code": "D018908",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.593"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de la tête tombante",
"alternateName": "Dropped Head Syndrome",
"url": "https://questionsmedicales.fr/mesh/D000094222",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de la tête tombante",
"code": {
"@type": "MedicalCode",
"code": "D000094222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.593.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Amyotrophie",
"alternateName": "Muscular Atrophy",
"url": "https://questionsmedicales.fr/mesh/D009133",
"about": {
"@type": "MedicalCondition",
"name": "Amyotrophie",
"code": {
"@type": "MedicalCode",
"code": "D009133",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.612"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Sarcopénie",
"alternateName": "Sarcopenia",
"url": "https://questionsmedicales.fr/mesh/D055948",
"about": {
"@type": "MedicalCondition",
"name": "Sarcopénie",
"code": {
"@type": "MedicalCode",
"code": "D055948",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.612.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Myokymie",
"alternateName": "Myokymia",
"url": "https://questionsmedicales.fr/mesh/D020385",
"about": {
"@type": "MedicalCondition",
"name": "Myokymie",
"code": {
"@type": "MedicalCode",
"code": "D020385",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.650"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Myotonie",
"alternateName": "Myotonia",
"url": "https://questionsmedicales.fr/mesh/D009222",
"about": {
"@type": "MedicalCondition",
"name": "Myotonie",
"code": {
"@type": "MedicalCode",
"code": "D009222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Spasme",
"alternateName": "Spasm",
"url": "https://questionsmedicales.fr/mesh/D013035",
"about": {
"@type": "MedicalCondition",
"name": "Spasme",
"code": {
"@type": "MedicalCode",
"code": "D013035",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Spasme hémifacial",
"alternateName": "Hemifacial Spasm",
"url": "https://questionsmedicales.fr/mesh/D019569",
"about": {
"@type": "MedicalCondition",
"name": "Spasme hémifacial",
"code": {
"@type": "MedicalCode",
"code": "D019569",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.750.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trismus",
"alternateName": "Trismus",
"url": "https://questionsmedicales.fr/mesh/D014313",
"about": {
"@type": "MedicalCondition",
"name": "Trismus",
"code": {
"@type": "MedicalCode",
"code": "D014313",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.750.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Tétanie",
"alternateName": "Tetany",
"url": "https://questionsmedicales.fr/mesh/D013746",
"about": {
"@type": "MedicalCondition",
"name": "Tétanie",
"code": {
"@type": "MedicalCode",
"code": "D013746",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Manifestations neuromusculaires",
"alternateName": "Neuromuscular Manifestations",
"code": {
"@type": "MedicalCode",
"code": "D020879",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Michael S Cartwright",
"url": "https://questionsmedicales.fr/author/Michael%20S%20Cartwright",
"affiliation": {
"@type": "Organization",
"name": "Neurology Department, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA."
}
},
{
"@type": "Person",
"name": "Heinz Jungbluth",
"url": "https://questionsmedicales.fr/author/Heinz%20Jungbluth",
"affiliation": {
"@type": "Organization",
"name": "Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom; Randall Centre for Cell and Molecular Biophysics, Muscle Signalling Section, Faculty of Life Sciences and Medicine (FoLSM), King's College London, London, United Kingdom. Electronic address: Heinz.Jungbluth@gstt.nhs.uk."
}
},
{
"@type": "Person",
"name": "David Lacomis",
"url": "https://questionsmedicales.fr/author/David%20Lacomis",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA, United States."
}
},
{
"@type": "Person",
"name": "Miguel A Fernandez-Garcia",
"url": "https://questionsmedicales.fr/author/Miguel%20A%20Fernandez-Garcia",
"affiliation": {
"@type": "Organization",
"name": "Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom."
}
},
{
"@type": "Person",
"name": "Ruple S Laughlin",
"url": "https://questionsmedicales.fr/author/Ruple%20S%20Laughlin",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cost-benefit analysis of a distracted pedestrian intervention.",
"datePublished": "2022-11-17",
"url": "https://questionsmedicales.fr/article/36396441",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/ip-2022-044740"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-Benefit Analysis of Tafenoquine for Radical Cure of",
"datePublished": "2022-07-11",
"url": "https://questionsmedicales.fr/article/35818703",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3346/jkms.2022.37.e212"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt.",
"datePublished": "2022-09-07",
"url": "https://questionsmedicales.fr/article/36070504",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/21645515.2022.2114252"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-Benefit Analysis versus Cost-Effectiveness Analysis from a Societal Perspective in Healthcare.",
"datePublished": "2023-03-06",
"url": "https://questionsmedicales.fr/article/36901658",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20054637"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cashing in: cost-benefit analysis framework for digital hospitals.",
"datePublished": "2024-05-31",
"url": "https://questionsmedicales.fr/article/38822341",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-024-11132-7"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Signes et symptômes",
"item": "https://questionsmedicales.fr/mesh/D012816"
},
{
"@type": "ListItem",
"position": 4,
"name": "Manifestations neurologiques",
"item": "https://questionsmedicales.fr/mesh/D009461"
},
{
"@type": "ListItem",
"position": 5,
"name": "Manifestations neuromusculaires",
"item": "https://questionsmedicales.fr/mesh/D020879"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Manifestations neuromusculaires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Manifestations neuromusculaires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Manifestations neuromusculaires",
"description": "Comment diagnostiquer une myopathie ?\nQuels examens pour les neuropathies ?\nQuel rôle des tests génétiques ?\nComment évaluer la force musculaire ?\nQuand faire une IRM musculaire ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Cost-Benefit+Analysis#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Manifestations neuromusculaires",
"description": "Quels sont les symptômes d'une dystrophie musculaire ?\nComment se manifeste une neuropathie périphérique ?\nQuels signes d'une myasthénie ?\nQuels symptômes d'une sclérose latérale amyotrophique ?\nComment reconnaître un syndrome de Guillain-Barré ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Cost-Benefit+Analysis#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Manifestations neuromusculaires",
"description": "Peut-on prévenir les neuropathies ?\nComment prévenir les crampes musculaires ?\nY a-t-il des mesures préventives pour la myopathie ?\nComment éviter les blessures musculaires ?\nPeut-on prévenir la sclérose latérale amyotrophique ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Cost-Benefit+Analysis#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Manifestations neuromusculaires",
"description": "Quels traitements pour la myopathie ?\nComment traiter une neuropathie diabétique ?\nQuel est le traitement de la myasthénie ?\nQuelles options pour la sclérose latérale amyotrophique ?\nComment gérer le syndrome de Guillain-Barré ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Cost-Benefit+Analysis#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Manifestations neuromusculaires",
"description": "Quelles complications des myopathies ?\nQuels risques avec la neuropathie ?\nQuelles complications de la myasthénie ?\nQuels problèmes liés à la sclérose latérale amyotrophique ?\nQuelles complications du syndrome de Guillain-Barré ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Cost-Benefit+Analysis#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Manifestations neuromusculaires",
"description": "Quels facteurs de risque pour les myopathies ?\nQuels risques pour la neuropathie diabétique ?\nQuels facteurs de risque pour la myasthénie ?\nQuels risques pour la sclérose latérale amyotrophique ?\nQuels facteurs de risque pour le syndrome de Guillain-Barré ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Cost-Benefit+Analysis#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une myopathie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic de myopathie nécessite un examen clinique, des tests sanguins et une biopsie musculaire."
}
},
{
"@type": "Question",
"name": "Quels examens pour les neuropathies ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les neuropathies sont diagnostiquées par électromyogramme (EMG) et études de conduction nerveuse."
}
},
{
"@type": "Question",
"name": "Quel rôle des tests génétiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests génétiques aident à identifier des maladies neuromusculaires héréditaires spécifiques."
}
},
{
"@type": "Question",
"name": "Comment évaluer la force musculaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La force musculaire est évaluée par des tests de force manuelle et des échelles standardisées."
}
},
{
"@type": "Question",
"name": "Quand faire une IRM musculaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM musculaire est indiquée pour visualiser des anomalies structurelles dans les muscles."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une dystrophie musculaire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent faiblesse musculaire progressive, crampes et difficultés à marcher."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une neuropathie périphérique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des douleurs, des picotements et une perte de sensation dans les membres."
}
},
{
"@type": "Question",
"name": "Quels signes d'une myasthénie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fatigue musculaire, ptosis (chute des paupières) et troubles de la déglutition."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une sclérose latérale amyotrophique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent faiblesse musculaire, crampes et difficultés à parler et à avaler."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un syndrome de Guillain-Barré ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il se manifeste par une faiblesse musculaire rapide, des picotements et des réflexes diminués."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les neuropathies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut le contrôle des maladies chroniques comme le diabète et l'évitement des toxines."
}
},
{
"@type": "Question",
"name": "Comment prévenir les crampes musculaires ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation, l'étirement régulier et une alimentation équilibrée aident à prévenir les crampes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour la myopathie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de prévention spécifique, mais un diagnostic précoce peut aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Comment éviter les blessures musculaires ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un échauffement adéquat, des exercices appropriés et une bonne technique réduisent les blessures."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la sclérose latérale amyotrophique ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de méthode prouvée pour prévenir la sclérose latérale amyotrophique."
}
},
{
"@type": "Question",
"name": "Quels traitements pour la myopathie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des corticostéroïdes, de la physiothérapie et des médicaments immunosuppresseurs."
}
},
{
"@type": "Question",
"name": "Comment traiter une neuropathie diabétique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend le contrôle de la glycémie, des analgésiques et des thérapies physiques."
}
},
{
"@type": "Question",
"name": "Quel est le traitement de la myasthénie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut des inhibiteurs de l'acétylcholinestérase et parfois des immunosuppresseurs."
}
},
{
"@type": "Question",
"name": "Quelles options pour la sclérose latérale amyotrophique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les options incluent des médicaments pour ralentir la progression et des soins palliatifs."
}
},
{
"@type": "Question",
"name": "Comment gérer le syndrome de Guillain-Barré ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des immunoglobulines intraveineuses et une rééducation physique."
}
},
{
"@type": "Question",
"name": "Quelles complications des myopathies ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des déformations squelettiques, des problèmes respiratoires et cardiaques."
}
},
{
"@type": "Question",
"name": "Quels risques avec la neuropathie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des blessures dues à une perte de sensation et des infections cutanées."
}
},
{
"@type": "Question",
"name": "Quelles complications de la myasthénie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des crises myasthéniques, affectant la respiration et la déglutition."
}
},
{
"@type": "Question",
"name": "Quels problèmes liés à la sclérose latérale amyotrophique ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les problèmes incluent la paralysie progressive, des difficultés respiratoires et des infections."
}
},
{
"@type": "Question",
"name": "Quelles complications du syndrome de Guillain-Barré ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des problèmes respiratoires, des douleurs chroniques et des séquelles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour les myopathies ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des infections virales et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Quels risques pour la neuropathie diabétique ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diabète mal contrôlé, l'obésité et l'hypertension augmentent le risque de neuropathie."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la myasthénie ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des maladies auto-immunes, des infections et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quels risques pour la sclérose latérale amyotrophique ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs de risque incluent l'âge avancé, le sexe masculin et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le syndrome de Guillain-Barré ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections virales, notamment la grippe, et des antécédents de vaccination peuvent être des facteurs de risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 07/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Neurology Department, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Publications dans "Manifestations neuromusculaires" :
3 publications dans cette catégorie
Affiliations :
Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom; Randall Centre for Cell and Molecular Biophysics, Muscle Signalling Section, Faculty of Life Sciences and Medicine (FoLSM), King's College London, London, United Kingdom. Electronic address: Heinz.Jungbluth@gstt.nhs.uk.
Publications dans "Manifestations neuromusculaires" :
3 publications dans cette catégorie
Affiliations :
Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.
Department of Pathology (Neuropathology), University of Pittsburgh Medical Center, Pittsburgh, PA, United States.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Division of Neuromuscular Diseases, Neuropathology Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Malignant Hyperthermia Investigation Unit, Department of Anaesthesiology, Canisius Wilhelmina Hospital Nijmegen, Nijmegen, The Netherlands.
Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Malignant Hyperthermia Investigation Unit, Department of Anaesthesiology and Pain Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Malignant Hyperthermia Investigation Unit, Department of Anaesthesiology, Canisius Wilhelmina Hospital Nijmegen, Nijmegen, The Netherlands.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Human Performance Laboratory, Schulthess Clinic, Zurich, Switzerland.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Sport Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Sport Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology and Neurological Sciences, Stanford University, Stanford, California.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Division of Neuromuscular Medicine, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Publications dans "Manifestations neuromusculaires" :
1 publication dans cette catégorie
Affiliations :
Senior Consultant and Associate Professor of Neurology, Fortis Hospital, Mumbai, Maharashtra, India.
Publications dans "Manifestations neuromusculaires" :
1 publication dans cette catégorie
Affiliations :
Dean, Bombay Hospital Institute of Medical Sciences, Mumbai, Maharashtra, India.
Publications dans "Manifestations neuromusculaires" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Publications dans "Manifestations neuromusculaires" :
Cellphone ubiquity has increased distracted pedestrian behaviour and contributed to growing pedestrian injury rates. A major barrier to large-scale implementation of prevention programmes is unavailab...
Three data sources were used as follows: (1) fatal, severe, non-severe pedestrian injury rates from Alabama's electronic crash reporting system; (2) expected costs per fatal, severe, non-severe pedest...
Over 2019-2021, Alabama recorded an annual average of 31 fatal, 83 severe and 115 non-severe pedestrian injuries in intersections. Expected costs/injury were US$11 million, US$339 535 and US$93 877, r...
Even under the most parsimonious scenario (25% distracted pedestrians; densest beacon placement), StreetBit yields US$11.8 million estimated net annual benefit to society. Existing data sources can be...
We expanded the previously developed...
Under 0.04 primaquine relapse probability, the introduction of tafenoquine with relapse probability of 0.01 prevented 129 (12.27%) and 35 (77.78%) total and relapse cases, respectively, over the next ...
Tafenoquine could reduce...
New vaccine introductions (NVIs) raise issues of value for money (VfM) for self-financing middle-income countries like Egypt. We evaluate a pediatric pneumococcal conjugate vaccine (PCV) NVI in Egypt ...
Cost-effectiveness analysis (CEA) is the main way that economic evaluations are carried out in the health care field. However, CEA has limited validity in deciding whether any health care evaluation i...
For many countries, especially those outside the USA without incentive payments, implementing and maintaining electronic medical records (EMR) is expensive and can be controversial given the large amo...
This paper outlines the development of an evidence-based digital health cost-benefit analysis (eHealth-CBA) framework to calculate the total economic value of the EMR implementation over time. A net p...
We developed a three-stage process that takes into account the complexity of the healthcare system and its stakeholders, the investment appraisal and evaluation practice, and the existing knowledge of...
The proposed framework is the first step toward developing a comprehensive evaluation framework for EMRs to inform health decision-makers about the economic value of digital investments rather than ju...
Broad benefits of vaccination programs are well acknowledged but difficult to measure, especially when considering all vaccines included in a National Immunization Program (NIP). The aim was to conduc...
When a viral outbreak occurs, governments are obligated to protect their citizens from the diverse adverse effects of the disease. Health policymakers often have several interventions to consider base...
Despite increasing global attention to the national human papillomavirus (HPV) immunization program, this program is controversial in Iran. Evidence indicates that HPV vaccination is not cost-effectiv...
Laboratories and their criminal justice systems are confronted with challenges for implementing new technologies, practices, and policies even when there appears to be demonstrative benefits to operat...
The multiple hypothesis testing problem is inherent in large-scale quantitative "omic" experiments such as mass spectrometry-based proteomics. Yet, tools for comparing the costs and benefits of differ...